×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
Download -
Business Today | August 31, 2014 of Fame... · KIRAN MAZUMDAR-SHAW CMD. Biocon Ltd In January, her company's partnership with Mylan launch a biosimilar and a targeted therapy to treat
Download
Transcript
Page 1
Business Today | August 31, 2014
Top Related
Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
Mylan and Biocon obtain firstUSr ival to Herceptin · 2018. 11. 20. · 2 GENERICSbulletin 8D ecember2017 COMPANY NEWS MANUFACTURING Reddy’scanresume producingforEurope DrR eddy’s
NOT A SHARK IN A SUIT. NOT A CORPORATE WOLF. IN … · Kiran Mazumdar Shaw Sadhguru - Yogi, Mystic & Founder of Isha Foundation Kiran Mazumdar Shaw - Chairperson and MD, BIOCON Vijay
NOT A SHARK IN A SUIT. NOT A CORPORATE WOLF. IN · PDF fileKiran Mazumdar Shaw Sadhguru - Yogi, Mystic & Founder of Isha Foundation Kiran Mazumdar Shaw - Chairperson and MD, BIOCON
BIOCON Q1FY2005 RESULTS CONFERENCE CALL … Call/132523_20040714.pdf · Kiran Mazumdar-Shaw: Well, we are still confident of launching it in the first half. We are only awaiting final
Kiran Mazumdar-Shaw 1 - Biocon · Flexible service models including FTE/FFS, Co -development and Risk Sharing Strong infrastructure in early clinical development and translational
OMPI - World Intellectual Property Organization...Kiran Mazumdar-Shaw, de Biocon, transforma la salud mundial 34 Igualdad de género en la agricultura africana: un imperativo para
Biocon Limited’s Q3 FY15 Earnings Conference Call … Call/132523_20150123.pdfKiran Mazumdar-Shaw:So let me answer the second question and I will get Peter Bains to answer the first